Glenmark Pharmaceuticals Limited Share Price Bombay S.E.
Stocks
GLENMARK
INE935A01035
Pharmaceuticals
|
Market Closed -
Bombay S.E.
11:02:32 06/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,288.95 INR | +0.32% |
|
-2.01% | +12.43% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
| Market Cap | 652B 6.77B 6.01B 5.62B 5.09B 9.62B 9.69B 67.5B 26.25B 333B 25.39B 24.85B 1,070B | P/E 2027 * |
28x | P/E 2028 * | 23.3x |
|---|---|---|---|---|---|
| Enterprise Value | 616B 6.39B 5.67B 5.31B 4.81B 9.08B 9.15B 63.72B 24.78B 314B 23.97B 23.46B 1,010B | EV / Sales 2027 * |
3.66x | EV / Sales 2028 * | 3.22x |
| Free-Float |
51.04% | Yield 2027 * |
0.17% | Yield 2028 * | 0.18% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLENMARK | Delayed | |
Bombay S.E.
| GLENMARK | Delayed |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +0.32% | ||
| 1 week | -2.01% | ||
| Current month | -0.91% | ||
| 1 month | -5.69% | ||
| 3 months | +3.58% | ||
| 6 months | +9.29% | ||
| Current year | +12.43% |
| 1 week | 2,273.7 |  | 2,413.4 |
| 1 month | 2,273.7 | | 2,491.2 |
| Current year | 1,842.8 | | 2,536.85 |
| 1 year | 1,794 | | 2,536.85 |
| 3 years | 702.05 | | 2,536.85 |
| 5 years | 348.9 | | 2,536.85 |
| 10 years | 168 | | 2,536.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 26/05/2025 |
Indrajit Bose
PSD | President | - | 14/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 86 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.32% | -2.01% | - | - | 6.72B | |
| +1.80% | -2.02% | +37.35% | +105.34% | 1,019B | |
| +0.57% | -4.85% | +35.31% | +61.50% | 610B | |
| +0.84% | +1.79% | +16.43% | +80.79% | 470B | |
| +1.49% | -4.92% | +59.83% | +36.63% | 344B | |
| +0.26% | +0.14% | +21.29% | +40.99% | 336B | |
| +0.60% | -3.09% | +10.76% | +32.59% | 266B | |
| +1.65% | -3.78% | -6.03% | +9.29% | 241B | |
| -0.25% | -5.11% | +36.68% | +50.29% | 218B | |
| -0.45% | -4.96% | +26.58% | +92.36% | 179B | |
| Average | +0.67% | -3.63% | +26.46% | +56.64% | 409.2B | |
| Weighted average by Cap. | +0.96% | -3.51% | +29.65% | +67.22% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 168B 1.75B 1.55B 1.45B 1.31B 2.48B 2.5B 17.42B 6.78B 85.86B 6.55B 6.41B 276B | 187B 1.94B 1.73B 1.61B 1.46B 2.76B 2.78B 19.39B 7.54B 95.57B 7.29B 7.14B 307B |
| Net income | 23.34B 242M 215M 201M 182M 344M 347M 2.42B 940M 11.91B 909M 889M 38.28B | 27.97B 290M 258M 241M 219M 413M 416M 2.9B 1.13B 14.27B 1.09B 1.07B 45.88B |
| Net Debt | -36.49B -379M -336M -314M -285M -538M -542M -3.78B -1.47B -18.62B -1.42B -1.39B -59.84B | -48B -498M -442M -414M -375M -708M -713M -4.97B -1.93B -24.49B -1.87B -1.83B -78.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/10/26 | ₹2,288.95 | +0.32% | 13,398 |
| 05/10/26 | ₹2,281.60 | -2.34% | 15,494 |
| 01/10/26 | ₹2,336.30 | +1.14% | 35,968 |
| 30/09/26 | ₹2,309.90 | -3.55% | 31,273 |
| 29/09/26 | ₹2,395.00 | +2.53% | 36,513 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
